Jobs

Discover opportunities across our network
Camford Capital
Camford Capital
22
companies
202
Jobs
Powered by Getro
Showing 22 companies
Ceribell
Ceribell
44 jobs
Biotechnology
DeepTech
Health
201 - 1000
Series C+

Ceribell focuses on making electroencephalography (EEG) widely accessible, more efficient, and more cost-effective. The company creates and validates an FDA cleared instant EEG system that does not require an EEG technologist or specialist interpreter, which allows for faster results and clinical decision making. The Ceribell EEG System can be set up by any healthcare provider in 6 minutes and offers a proprietary Brain Stethoscope function that dramatically simplifies interpretation of EEG results by converting brainwaves to sound so seizures can be detected by listening. Earlier diagnosis and focused treatment for patients with seizures, including non-convulsive seizures that can only be diagnosed with EEG, can significantly lower mortality, secondary brain injury, length of stay, and risk of complications.

Cobo
Cobo
41 jobs
Blockchain and Crypto
Finance
Software
51 - 200
Series B

Cobo is a globally trusted leader in digital asset custody solutions. Established in 2017 and headquartered in Singapore, our industry-leading custody technologies inspire confidence in digital asset ownership by enabling safe and efficient management of digital assets and interactions with Web 3.0. As a pioneering omni-custody platform, Cobo offers the full spectrum of custody technologies designed specifically to cater to the unique needs of institutions. From custodial wallets to non-custodial wallets including advanced multi-party computation (MPC) and smart contract wallets, we empower institutions to secure and manage their digital assets their way. In addition, Cobo provides Wallet-as-a-Service, SuperLoop (off-exchange settlement network), and Argus (on-chain digital asset management platform).

Biotechnology
DeepTech
Health
201 - 1000

Beam Therapeutics is a biotechnology company engaged in creating genetic medicines based on its base editing technology. Beam is pioneering the use of base editing, a potential new class of precision genetic medicines, with a vision of providing life-long cures to patients suffering from serious diseases. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.

CertiK
CertiK
21 jobs
Blockchain and Crypto
Security
Software
201 - 1000
Series B

CertiK is a pioneer in blockchain security, leveraging best-in-class AI technology to protect and monitor blockchain protocols and smart contracts. Founded in 2018 by professors from Yale University and Columbia University, CertiK’s mission is to secure the web3 world. CertiK applies cutting-edge innovations from academia to enterprise, enabling mission-critical applications to scale with safety and correctness.

Viz.ai
Viz.ai
15 jobs
Data and Analytics
DeepTech
Health
Software
201 - 1000

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care, covering more than 220 million lives across 1,600+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz.ai® One is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, Viz.ai One delivers significant value to patients, providers, and pharmaceutical and medical device companies.

Biotechnology
DeepTech
Health
51 - 200
Series C+

CG Oncology formerly known as Cold Genesys is a privately held, clinical-stage biopharmaceutical company that focuses on the research, acquisition, and development of novel immunotherapies. It specializes in the development of oncolytic immunotherapies to combat cancer, providing patients with new and impactful therapies. CG Oncology acquired the rights to develop CG0070 from BioSante Pharmaceuticals (Nasdaq: BPAX). A phase I/IIa dose-escalating clinical trial has already been completed in 35 patients with NMIBC. Cold Genesys is hopeful to get this therapy back into the clinical setting with the initiation of the proposed phase II/III trial.

DFINITY
DFINITY
11 jobs
Blockchain and Crypto
Finance
Internet Services
Software
201 - 1000

The DFINITY Foundation’s mission is to build, promote, and maintain the Internet Computer — the world’s first web-speed, internet-scale public blockchain. It enables smart contracts to securely serve interactive web content directly into the browsers of end users, making it possible to build dapps, DeFi, open internet services, and enterprise systems that are capable of operating at hyperscale. The Internet Computer uses smart contracts to power an emerging decentralized ecosystem of interoperable dapps and services, where nearly every system and service can run in reimagined form on public blockchain.

InfStones
InfStones
8 jobs
Blockchain and Crypto
Hardware
Internet Services
11 - 50
Series C+

Founded in 2018 with offices across three countries and two continents, InfStones is the world's leading blockchain infrastructure provider. Currently, InfStones provides services to large institutional clients around the globe, supporting thousands of nodes on more than 50 public blockchains through its universal platform.

SFOX
SFOX
7 jobs
Blockchain and Crypto
Finance
Lending and Investments
Software
51 - 200
Series A

SFOX is a cryptocurrency prime dealer that provides professional traders and institutional investors higher returns when trading large volumes, through smart routing and a global integrated order book.

Biotechnology
DeepTech
Health
51 - 200
Series C+

Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term curative therapies, as well as other applications such as decentralized precision diagnostics. Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, the company’s ultracompact proteins are designed to enable in vivo gene editing in difficult to reach tissues utilizing both nuclease applications and new editing modalities beyond double stranded breaks, including base editing, gene writing, and epigenetic editing. The company is building out its pipeline of potential in vivo gene editing therapeutics and capabilities and has partnerships with leading pharmaceutical and biotechnology companies to broaden the reach of its innovative and proprietary technology. Mammoth’s deep science and industry experience, along with a robust and differentiated intellectual property portfolio, have enabled the company to further its mission to transform the lives of patients and deliver on the full promise of CRISPR technologies.

PathAI
PathAI
4 jobs
Biotechnology
DeepTech
Health
201 - 1000

PathAI’s services solve challenging pathology problems faced by the research and pharmaceutical industry. The PathAI platform provides end-to-end automation for reliable, scalable, and cost-effective long-term solutions. PathAI is developing technology that assists pathologists in making rapid and accurate diagnoses for every patient, every time. The company was founded in 2016 and based in Boston, Massachusetts.

Biotechnology
DeepTech
Health
11 - 50
Series A

Totus Medicines uses revolutionary chemical biology to create life-changing therapies to treat previously untreatable diseases across the entire human genome.